GlassScriptPhysician profile
Shenia Johnson
NPI 1538777529
$2,642.36
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $518 · 2022: $392 · 2023: $869 · 2024: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,732.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $357.04 | 2021-2024 | |
| Abbvie INC. | $281.89 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $234.20 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $214.22 | 2021-2023 | Lokelma |
| Lundbeck LLC | $156.87 | 2024 | Vyepti |
| Novo Nordisk INC | $148.39 | 2023 | Novoseven |
| Sanofi-Aventis U.S. LLC | $139.19 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.01 | 2023 | |
| Paratek Pharmaceuticals, INC. | $125.00 | 2023 | Nuzyra |
| Neurelis, INC. | $123.58 | 2023 | Valtoco |
| Inspire Medical Systems, INC. | $112.81 | 2024 | Inspire |
| Janssen Biotech, INC. | $88.75 | 2024 | Stelara, Tremfya |
| Ucb, INC. | $82.87 | 2024 | Nayzilam |
| Corcept Therapeutics | $77.70 | 2024 | Korlym |
| Biohaven Pharmaceutical Holding Company LTD. | $73.42 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $72.39 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $68.24 | 2024 | Austedo Xr |
| Lilly USA, LLC | $52.83 | 2021-2022 | |
| Gilead Sciences, INC. | $47.27 | 2023 | Epclusa |
| Daiichi Sankyo INC. | $37.47 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shenia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.